MedPath

MINT-ACARBOSE

MINT-ACARBOSE

Approved
DIN Number

02493799

Drug Class

Human

Market Date

May 28, 2020

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02493799
AIG Number0123099001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BF01 ACARBOSE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.02
Health Canada Classification

ACTIVE INGREDIENTS (1)

ACARBOSEActive
Strength: 100 MG
Monograph: ACARBOSE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.